TUCSON, Ariz. (AP) _ Accelerate Diagnostics Inc. (AXDX) on Thursday reported a loss of $21.7 million in its first quarter.
The Tucson, Arizona-based company said it had a loss of 40 cents per share.
The results topped Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 43 cents per share.
The maker of systems that diagnose drug-resistant infections posted revenue of $1.8 million in the period, which missed Street forecasts. Three analysts surveyed by Zacks expected $2.1 million.
Accelerate Diagnostics shares have risen 72% since the beginning of the year. In the final minutes of trading on Thursday, shares hit $19.77, a fall of 12% in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AXDX at https://www.zacks.com/ap/AXDX